Main Sequence Ventures manages the $240 AUD million CSIRO Innovation Fund that invests in deep tech high growth startups based out of research.
Humanity Scale Healthcare
How will we diagnose and treat illness faster, cheaper + better?
How will we feed 10B people given planetary boundaries?
Space & New Transport
How will access to space enable new industries? How will transportation change?
How will we learn, work, and stay safe from new threats?
How can we satisfy our appetite for connectivity and computing power?
Why We’re Different
Dedicated focus on deep tech companies with global ambitions
Unique deal flow from research relationships and strategy of company creation and spinouts
Experienced team with strong networks for deal flow, talent and coinvestment
Testing & Certification
Deep Scale Up Facilities
Who is the Fund Suitable for
The Fund is best suited to wholesale investors who:
- seek investments in early stage, high growth technology companies
- understand and are willing to accept a high level of risk for the potential to generate strong returns
- have an investment horizon greater than 10 years
- seek tax-effective investment strategies
Wholesale & Sophisticated Investors
Register to receive our Fund 2 Information Sheet.